GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery  + Monitoring   + Drug Therapeutics   + Medical Devices  + Pain & CNS   + Tissue
 
Prefilled Syringes to 2018
Devices, Drugs, Markets, Players and Prospects


About This Report

Price: US $3,850

Publication: March 2013

Product Code: PSJ169F







Drug Delivery Reports

Prefilled Syringes to 2018
Pen Injectors
Sustained Release Injectables
Injectable Drug Delivery 2016
Cartridge-based Injectors
Integrated Safety Syringes
Drug Reconstitution Systems
Autoinjectors to 2016
Dual Chamber Injectors
Needle-free Injectors
IV Fluid Transfer Devices
Smart Infusion Pumps
Inhaled Drug Delivery to 2016
Dry Powder Inhalation
Inhaled CNS Therapeutics
Pulmonary Inhalers
Inhaled Pain Management
Prescription Drug Patches
Microneedle Drug Delivery
Patch Pump Drug Delivery
Transdermal CNS Therapeutic
Needle Array Drug Delivery
Transdermal Pain Mgmt
Oral Transmucosal Delivery
Iontophoresis Drug Delivery
Therapeutic Proteins to 2016
Pediatric Drug Delivery
Closed Drug Transfer System
Drug Self-Administration 2016
Drug Solubiity
 
 
 
 
 
 
 
 
 
 
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.
Highlights

· Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics

· Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

· Examines design factors, material selection issues, technologies and market development issues

· Charts product data, market share, and forecasts to 2018

· Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations
Table of Contents
Executive Summary

Injectable Drug Market Dynamics

Competitive Landscape
The Device Manufacturing Universe
Supply Chain Dynamics
Supply Chain Structure
Supplier Relationships and Supply Risk
Supplier Integration
Captive Capacity vs CMOs
Demand Drivers
Drug Discovery and Development Trends
Patient and Caregiver Sentiment
Diseases and Indications
Patient Demographics

The Prefilled Syringe Ecosystem and Supply Chain

Materials and Components
Evolving Technology
Alliances & Relationships
Syringe Manufacturers
Technology/Capabilities
Geographic Reach
Barriers to Entry
CMO’s – Beyond Fill & Finish
Value-added Services
Market Proximity
CMO Evolution
Testing, Services and Validation

Prefilled Syringes – Design Factors

Drug Stability and Shelf Life
Material Selection Issues
Point-of-Use Reconstitution
Caregiver Safety
Needle Configuration Strategies
Human Engineering/Ergonomics

Prefilled Syringes – Commercial Devices

Prefillable Therapeutic Injectables
Glass Prefillable Syringes
Plastic Prefillable Syringes
Ready-to-Fill Safety Syringes

Specialty Prefillable Syringes
Flush Syringes
Diluent Syringes
Imaging Agent Syringes

Competing Prefilled Devices
Bundled PFS + Autoinjector
Prefilled Pen Injectors
Prefilled Needle-free Injectors

Prefilled Syringe Market Segments

Prefilled Therapeutic Injectables

Anaphylaxis
Anticoagulants
Autoimmune Diseases
Emergency Medicine
Hepatitis
Hematopoietics and Related Erythropoiesis Stimulating Proteins
Metabolic Diseases
Neurology
Reproductive Health
Vaccines

Non-API Prefilled Syringe Segments

Catheterization
Reconstitution
Diagnostic Imaging 

Market Factors

Self-Administration and Patient Compliance
Insurance, Reimbursement, and Managed Care
Regulatory Guidance and Product Approvals
The Evolving PFS Ecosystem

Prefilled Syringes – Market Participant Profiles




 

 

Recent Research

Prefilled Syringes to 2018

Pen Injectors

Drug Self-Administration

Injectable Drug Delivery to 2018

Autoinjectors to 2018


Events

Drug Delivery & Formulation Summit - San Diego (April 2013)

Partnerships in Drug Delivery  - Boston (October 2013)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2013 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career